PureTech Health plc
NASDAQ:PRTCBiotechnology
Healthcare
$17.38 +2.64%
+$0.45 today
- Market cap
- $423.09M
- Beta
- 0.79
- P/E (TTM)
- -0.4
- EPS (TTM)
- -$45.37
52W Low $14.50High $19.92
Volume 0.01M
Average 0.01M
Income Statement
Follow revenue through to earnings.
Revenue
$4.66M
FY 2025 · Annual
-3.5% YoYOperating Income
-$98.53M
FY 2025 · Annual
Net Income
-$109.74M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 9.98M | 2.09M | 3.33M | 4.83M | 4.66M |
| Cost of Revenue | 110.47M | 152.43M | 4.93M | 3.57M | 3.36M |
| Gross Profit | (100.49M) | (136.82M) | (1.6M) | 1.26M | 4.66M |
| Gross Margin | -1007.0% | -6546.2% | -48.1% | 26.0% | 100.0% |
| Research & Development | 81.52M | 116.11M | 96.24M | 54.28M | 45.74M |
| Selling, General & Admin | 30.76M | 35.67M | 48.36M | 27.49M | 20.65M |
| Operating Expenses | 160.26M | 60.99M | 54.55M | 140.41M | 103.18M |
| Depreciation & Amortization | 7.24M | 8.89M | 4.93M | 3.57M | 3.35M |
| EBITDA | 26.7M | (188.91M) | (11.63M) | 37.38M | (61.8M) |
| EBITDA Margin | 267.6% | -9038.9% | -349.2% | 774.3% | -1326.5% |
| Operating Income | (150.28M) | (197.81M) | (146.2M) | (136.1M) | (98.53M) |
| Operating Margin | -1506.0% | -9464.4% | -4390.4% | -2818.9% | -2114.7% |
| Interest Income | 214K | 5.8M | 16.01M | 22.67M | 13.05M |
| Interest Expense | 4.71M | 3.95M | 13.49M | 10.04M | 45.78M |
| Other Income / Expenses | 91.33M | 105.02M | 110.1M | 159.87M | (12.4M) |
| Income Before Tax | (58.95M) | (92.78M) | (36.1M) | 23.77M | (110.93M) |
| Pre-Tax Margin | -590.8% | -4439.4% | -1084.2% | 492.4% | -2380.9% |
| Income Tax Expense | 3.76M | (55.72M) | 30.53M | (4.01M) | (842K) |
| Net Income | (60.56M) | (50.36M) | (65.7M) | 53.51M | (109.74M) |
| Net Margin | -606.9% | -2409.3% | -1972.9% | 1108.3% | -2355.4% |
| EPS (Basic) | (2.10) | (1.80) | (2.40) | 2.00 | (46.00) |
| EPS (Diluted) | (2.10) | (1.80) | (2.40) | 2.00 | (46.00) |
| 28.66M | 27.97M | 27.63M | 26.97M | 2.41M | |
| 28.66M | 28.48M | 27.63M | 26.97M | 2.41M |
PRTC Earnings Waterfall · TTM
NASDAQ:PRTC · Revenue to Net Income
Key Ratios
EPS$-26.80
Gross Margin-3388.5%
Net Margin-4216.9%
P/E Ratio-1.3
P/S Ratio656.8
Analysis
$9.0M of revenue converted into -$56.0M of net income for the selected period. Gross margin is -3388.5% and net margin is -4216.9%, showing how much revenue survives after costs and taxes. EPS is $-26.80, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| F-6 POS | F-6 POS filing | May 22, 2026 | |
| 15F-12B | 15F-12B filing | May 21, 2026 | |
| 424B3 | 424B3 filing | May 21, 2026 | |
| 25 | 25 filing | May 11, 2026 | |
| SC 13G/A | SC 13G/A filing | May 11, 2026 |
How much revenue does PRTC generate?
PureTech Health plc (PRTC) reported $4.66M of revenue in fiscal 2025.
Is PRTC profitable?
PureTech Health plc (PRTC) reported -$109.74M of net income, with a net margin of -2355.4%.
Continue the stock analysis
Jump to another research area for this company.